Embecta
EMBC
NASDAQ
IPO2022
about EMBC
Embecta specializes in developing innovative medical devices designed to improve patient care and manage chronic conditions.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $13.74 | $14.80 | $13.74 | $852.13M | 645.02K |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| +$0.78 | 7.77 | 2.97 | 31.81% | 15.40% | 4.00% |